Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials
Author:
Affiliation:
1. Division of Immunology, Biomedical Sciences Research Center “Alexander Fleming”Athens Greece
2. NovaMechanics Ltd Cheminformatics CompanyNicosia Cyprus
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21551
Reference120 articles.
1. Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase
2. J Chun Lysophospholipid receptors signaling and biochemistry 2013 John Wiley & Sons Inc Hoboken NJ 813
3. Lysophosphatidic acid (LPA) receptors: Signaling properties and disease relevance
4. Discovery of Highly Selective and Orally Active Lysophosphatidic Acid Receptor-1 Antagonists with Potent Activity on Human Lung Fibroblasts
5. The emerging role of lysophosphatidic acid in cancer;Mills GB;Nature Rev,2003
Cited by 35 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Review of Cyclic Phosphatidic Acid and Other Potential Therapeutic Targets for Treating Osteoarthritis;Biomedicines;2023-10-14
2. Pharmacokinetics, pharmacodynamics, safety and tolerability of FTP-198, a novel, selective Autotaxin inhibitor, in healthy subjects: A phase I randomized placebo-controlled trial;European Journal of Pharmaceutical Sciences;2023-10
3. Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models;Journal of Experimental & Clinical Cancer Research;2023-08-08
4. Dysregulation of metabolic pathways in pulmonary fibrosis;Pharmacology & Therapeutics;2023-06
5. RNA-seq reveals that anti-obesity irisin and triiodothyronine (T3) hormones differentially affect the purinergic signaling transcriptomics in differentiated human adipocytes;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2023-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3